$4.08
-0.20-4.67%
Last update: Nov 12, 10:31 AM
Taysha Gene Therapies Inc (TSHA) Stock Price, Quote, News & History
TSHANASDAQ
Taysha Gene Therapies (NASDAQ:TSHA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Taysha Gene Therapies (NASDAQ:TSHA) through any online brokerage.
Other companies in Taysha Gene Therapies’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Taysha Gene Therapies has a consensus price target of $11.13.
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $4.08 last updated November 12, 2026 at 10:31 AM EST.
There are no upcoming dividends for Taysha Gene Therapies.
Taysha Gene Therapies does not have any upcoming earnings scheduled.
There is no upcoming split for Taysha Gene Therapies.
Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in...
